what's glp 1 GLP-1 vs. GLP-1 + GIP: the Difference for your Metabolism? GLP-1 Weight Loss Options |
Description
The purpose of this review is to compare the clinical trial and real-world effectiveness data of glucagon-like peptide-1 receptor agonists versus sodiumglucose cotransporter 2 inhibitors related to A1c reduction, weight loss, cost-effectiveness, cardiovascular outcomes, and safety in patients with T2DM
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review
Furthermore, several novel therapeutic compounds (GIP receptor antagonists and agonists including multiple-targeting compounds) have also shown beneficial glucometabolic and body weight lowering effects in individuals with type 2 diabetes and obesity (40, 41)
Ledo JH, Azevedo EP, Clarke JR, Ribeiro FC, Figueiredo CP, Foguel D, et al
10.1038/nrn.2017.75 [DOI] [PubMed] [Google Scholar] 59.Ji C, Xue GF, Li G, Li D, Hlscher C
[DOI] [PubMed] [Google Scholar] 107.Naude J., Zentner A., Suresh P., Bittman J., Khan N.A
